62 filings
Page 2 of 4
8-K
orb3ttgflgx by5t
12 Dec 22
Harpoon Therapeutics Presents Updated Interim Results at ASH 2022 for Novel T Cell Engager HPN217 in Relapsed/Refractory Multiple Myeloma
4:03pm
8-K
yj7d04sc9j1mcjyp4a
1 Dec 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:06pm
8-K
iyvxgmxkk obutxjz
14 Nov 22
Harpoon Therapeutics Updates Strategic Priorities and Reports Third Quarter 2022 Financial Results
5:17pm
8-K
cnc6wldsy9clhz52k
19 Sep 22
Departure of Directors or Certain Officers
4:11pm
8-K
xra7btg0w wj
10 Aug 22
Harpoon Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:14pm
8-K
pawiy2k7
28 Jun 22
Departure of Directors or Certain Officers
4:02pm
8-K
mfveew5w vchqjrwh7n
3 Jun 22
Regulation FD Disclosure
5:05pm
8-K
5e9mawu
12 May 22
Harpoon Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:28pm
8-K
kre4h7ix j79bcui92
7 Apr 22
Departure of Directors or Certain Officers
4:16pm
8-K
ihyrzax
10 Mar 22
Harpoon Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
4:16pm
8-K
6kh9y6
11 Jan 22
Other Events
6:16am
8-K
7kofft
13 Dec 21
Other Events
5:28pm
8-K
hjh04vg
10 Nov 21
Harpoon Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update
4:41pm
8-K
d6edh0lb7rc4ra0yvwug
26 Oct 21
Departure of Directors or Certain Officers
4:19pm
8-K
w6v6ejld8p3unl09l
5 Aug 21
Harpoon Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update
4:22pm
8-K
nhvleut8qtd409reca
4 Jun 21
Harpoon Therapeutics Presents Updated Interim Clinical Data for the PSMA-targeting TriTACĀ® HPN424 at the 2021 ASCO Annual Meeting
4:40pm
8-K
2t3gl33 j1f
6 May 21
Harpoon Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
5:00pm
8-K
y0b5auw47ov n66b
26 Apr 21
Other Events
6:11am
8-K
mn22ow5f5
24 Mar 21
Departure of Directors or Certain Officers
4:49pm
8-K
kv3yzut
10 Mar 21
Harpoon Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
4:11pm